1. Oregon Prescription Drug Monitoring Program
Lisa Millet, Section Manager
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section, Public Health Division
Roseburg Opioid Summit, Umpqua Community College, March 21, 2017

2. Overview How PDMP can help, PDMP registration, and operation
Use of de-identified aggregated PDMP data for policy, practice and evaluation
Use of de-identified aggregated PDMP data for research
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section
Oregon Public Health Division

3. How PDMPs Can Help
Support medically necessary uses of controlled substances
Identify risks to patient safety
Facilitate coordination of care among providers
Aid in the identification of potential misuse, abuse, or diversion of prescription drugs
Assist in initiating compassionate conversations
Help the intervention and treatment of people addicted to prescription drugs
Help provide safer and more effective pain management for persons with chronic pain and limit risky prescribing to opioid naive
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section
Oregon Public Health Division

4. Oregon Law Allows the PDMP to Provide Retail Prescription Data to
Prescribers (MD, DO, NP, PA)
Pharmacists
Delegates (non-licensed staff of prescribers and pharmacists)
Licensing Boards
Patients
Medical Examiners
Law enforcement (with a court order)
Evaluation and research
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section
Oregon Public Health Division

5. Using the PDMP
Registration starts online with a second step of printing out a registration form and sending it to the PDMP office
Authorized account holders - prescribers and pharmacists (or their delegates) can query a 3 year prescription history of their patients
Can also query their DEA number to see all prescriptions filled under that number
Patients can request their own prescription history
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section
Oregon Public Health Division

6. Contact Information for PDMP Operations
Password resets and general help desk
(866)
Prescription Drug Monitoring Program
(971)
Oregon Prescription Drug Monitoring Program
Injury and Violence Prevention Section,
Oregon Public Health Division

7. Use of Aggregated De-Identified PDMP Data
Prescription Drug Overdose Prevention Grant
Create a “data dashboard” to VISUALIZE data
Displays prescribing trends and overdose outcomes
At the county, region and state levels
Interactive
Publically available
Useful for grantee regions and public
Embed on our website

8. The Dashboard
Healthoregon.org/opioids and look for the “Data Dashboard” link on the left
Tabs to navigate for deeper looks at prescribing, hospitalization, death, and technical notes
Scroll down for statewide hospitalization and death data

9. Statewide Measures – Prescribing (PDMP)

10. County Measures – Prescribing (PDMP)
Benzodiazepine Prescribing
Opioid Prescribing

11. County Measures – Prescribing (PDMP)
High Dose Opioid Prescribing
(>120 MED from single dose)
Opioid Prescribing

12. County Measures – Prescribing (PDMP)
High Dose Opioid Prescribing
(>120 MED from single dose)
Opioid Prescribing
Age Group

13. Statewide Measures – Hospitalization and Death

14. County Measures – Hospitalizations
Any Opioid Hospitalization by County
Any Opioid Hospitalization by Age

15. Research Using De-Identified PDMP Data, 2016
Josh Van Otterloo, MPH, PDMP Research Analyst
And Researchers at HealthInsight, OSU and OHSU

16. (Clackamas, Multnomah, Washington)
County Requests
Counties wanting to understand prescribing in their area
Central Oregon Health Council (Crook, Deschutes, Jefferson)
Metro Counties
(Clackamas, Multnomah, Washington)

17. OSU School of Pharmacy – Medicaid - Takeaways
Quantifies the amount of opioid fills dispensed to the Medicaid population that aren’t in the claims database (~13%)
Long acting opioids are more commonly paid out of pocket
Risky prescribing practices associated with cash payment
Only analyzing claims data to evaluate policy (such as prior authorization) overstates the impact of the policy

18. Acumentra / HealthInsight – Rick Deyo Takeaways
~5% of opioid initiators became long term users
Initial prescribing characteristics associated with long term use
Number of fills
Dose
Long-acting opioids
Suggests initiation with a single fill, low dose, short acting opioid
Supports CDC guideline

19. Acumentra / HealthInsight – Peter Geissert - Takeaways
Proactive alerts using only PDMP variables are going to have a low PPV and need to be carefully formulated so to avoid “alert fatigue”

20. Summary
Coordinating community efforts will reduce drug overdose, misuse, substance use disorder, diversion, and improve pain care. Risk reduction is an important public health goal.
Government + Private Sector + Community partnership focused on simultaneous implementation of key strategies will result in improved outcomes for patients, communities, and provide a return on investments made to address this multifaceted problem
Key strategies: implement prescribing guidelines, ensure access to MAT, expanding chronic pain care options, nalxone rescue
This is a winnable battle – we are:
saving lives,
improving pain care, patient safety & community safety, and
we can create a bridge to recovery for those that need it

21. Contact Lisa Millet, MSH
Injury and Violence Prevention Program Director
Oregon Public Health Division
Oregon Health Authority
PH: